Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
5,061,592
-
Total 13F shares
-
20,584
-
Share change
-
-15,119
-
Total reported value
-
$61,752
-
Price per share
-
$3.00
-
Number of holders
-
12
-
Value change
-
-$45,447
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q4 2024
As of 31 Dec 2024,
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,584 shares.
The largest 10 holders included
Connective Capital Management, LLC, MORGAN STANLEY, UBS Group AG, SBI Securities Co., Ltd., NATIONAL BANK OF CANADA /FI/, BANK OF AMERICA CORP /DE/, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, OSAIC HOLDINGS, INC., Federation des caisses Desjardins du Quebec, and TD Waterhouse Canada Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.